After identifying the Guanylate Cyclase C enzyme in the early 1990s, Scott Waldman, MD, and Adam Snook, MD, are set to take a vaccine that targets the enzyme to destroy metastatic tumors to a phase II trial in 2017.
The Latest
Inappropriate antibiotic prescribing is of increasing concern with at least 23,000 Americans dying from antibiotic-resistant bacteria each year.
A majority of stock analysts rated Laval, Canada-based Valeant Pharmaceuticals a 'hold,' the Cerbat Gem reports.
Marlborough, Mass.-based Boston Scientific completed its purchase of Alpharetta, Ga.-based EndoChoice for $210 million in cash, the Minnesota StarTribune reports.
The global surgical navigations systems market is expected to increase at a more than 7 percent compound annual growth rate through 2020, a Technavio report found.
Grey, Maine-based Enercon Technologies is expanding from its 35,000-square-foot headquarters to a new 69,000-square-foot facility, Worcester Business Journal reports.
The global surgical microscope market is projected to expand though 2022, a Research Beam report found, according to Whatech.
Fadi Annaba, MD, is a gastroenterologist at Springfield (Ill.) Clinic.
Here are 11 key points on ophthalmologists from the Medscape Compensation Report 2016.
Maintaining independence in the competitive healthcare industry will likely continue to challenge many surgery centers and providers. Omaha-based Advanced Surgery Center has faced some difficulty in the largely hospital-dominated marketplace. In Omaha, many hospitals own ASCs and hospitals often contract…
